AAAAAA

   
Results: 1-16 |
Results: 16
RECURRENT HEPATITIS-B - PREDICTIONS AND PROPHYLAXIS FOLLOWING LIVER-TRANSPLANTATION
Authors: MORGAN G DIFLO T JOHN D TOBIAS H TEPERMAN L
Citation: G. Morgan et al., RECURRENT HEPATITIS-B - PREDICTIONS AND PROPHYLAXIS FOLLOWING LIVER-TRANSPLANTATION, Hepatology, 28(4), 1998, pp. 2281-2281
SAFE AND COST-EFFECTIVE TOTAL PARACENTESIS WITHOUT ALBUMIN REPLACEMENT IN CIRRHOTIC-PATIENTS WITH TENSE ASCITES
Authors: COSTABLE JM JOHN DG COHEN J MORGAN GR DIFLO T TEPERMAN LW
Citation: Jm. Costable et al., SAFE AND COST-EFFECTIVE TOTAL PARACENTESIS WITHOUT ALBUMIN REPLACEMENT IN CIRRHOTIC-PATIENTS WITH TENSE ASCITES, Hepatology, 26(4), 1997, pp. 1467-1467
INTRAHEPATIC BILE-DUCT STRICTURES ARE NOT ASSOCIATED WITH PROLONGED COLD ISCHEMIC TIME
Authors: JOHN DG MORGAN GR DIFLO T NEGRON CE TOBIAS H TEPERMAN LW
Citation: Dg. John et al., INTRAHEPATIC BILE-DUCT STRICTURES ARE NOT ASSOCIATED WITH PROLONGED COLD ISCHEMIC TIME, Hepatology, 26(4), 1997, pp. 1616-1616
THE USE OF TIPS FOR REFRACTORY ASCITES IS MARGINALLY EFFECTIVE
Authors: JOHN DG ROSEN R SCHLOSSBERG P NEGRON CE DIFLO T MORGAN GR TEPERMAN LW
Citation: Dg. John et al., THE USE OF TIPS FOR REFRACTORY ASCITES IS MARGINALLY EFFECTIVE, Hepatology, 26(4), 1997, pp. 1617-1617
PLASMA-EXCHANGE (PEX) AS A BRIDGE TO SUCCESSFUL LIVER-TRANSPLANTATION(OLT) IN THE CRITICALLY ILL PATIENT
Authors: MORGAN GR CHEN D GOLDENBERG A TOBIAS H DIFLO T TEPERMAN L
Citation: Gr. Morgan et al., PLASMA-EXCHANGE (PEX) AS A BRIDGE TO SUCCESSFUL LIVER-TRANSPLANTATION(OLT) IN THE CRITICALLY ILL PATIENT, Hepatology, 26(4), 1997, pp. 1748-1748
SAFE AND COST-EFFECTIVE TOTAL PARACENTESIS WITHOUT ALBUMIN REPLACEMENT IN CIRRHOTIC-PATIENTS WITH TENSE ASCITES
Authors: COSTABLE JM JOHN DG COHEN J MORGAN GR DIFLO T TEPERMAN LW
Citation: Jm. Costable et al., SAFE AND COST-EFFECTIVE TOTAL PARACENTESIS WITHOUT ALBUMIN REPLACEMENT IN CIRRHOTIC-PATIENTS WITH TENSE ASCITES, Gastroenterology, 112(4), 1997, pp. 1248-1248
DILTIAZEM IS A SAFE DRUG IN TRANSPLANT PATIENTS ON PROGRAF AND DOES NOT AFFECT PROGRAF LEVELS
Authors: TEPERMAN L TURGUT S NEGRON C JOHN D DIFLO T MORGAN G TOBIAS H
Citation: L. Teperman et al., DILTIAZEM IS A SAFE DRUG IN TRANSPLANT PATIENTS ON PROGRAF AND DOES NOT AFFECT PROGRAF LEVELS, Hepatology, 24(4), 1996, pp. 214-214
THE USE OF PLASMA-EXCHANGE IN PRIMARY NON-FUNCTION OF LIVER ALLOGRAFTS
Authors: TEPERMAN L MORGAN G CHEN C CHEN D NEGRON C DIFLO T GOLDENBERG A
Citation: L. Teperman et al., THE USE OF PLASMA-EXCHANGE IN PRIMARY NON-FUNCTION OF LIVER ALLOGRAFTS, Hepatology, 24(4), 1996, pp. 215-215
INTRODUCTION IMMUNOTHERAPY IN LIVER-TRANSPLANTATION WITH MYCOPHENOLATE MOFETIL AND STEROIDS
Authors: JOHN D MORGAN G DIFLO T SIMONS C TOBIAS H TEPERMAN L
Citation: D. John et al., INTRODUCTION IMMUNOTHERAPY IN LIVER-TRANSPLANTATION WITH MYCOPHENOLATE MOFETIL AND STEROIDS, Hepatology, 24(4), 1996, pp. 1609-1609
WAITING TIME FOR LIVER-TRANSPLANTATION INCREASES THE RISK OF INCIDENTAL HEPATOCELLULAR CARCINOMAS FOUND IN EXPLANTS
Authors: TEPERMAN L MIZRACHI H JOHN D DIFLO T MORGAN G GOLDENBERG A TOBIAS H THEISE N
Citation: L. Teperman et al., WAITING TIME FOR LIVER-TRANSPLANTATION INCREASES THE RISK OF INCIDENTAL HEPATOCELLULAR CARCINOMAS FOUND IN EXPLANTS, Hepatology, 24(4), 1996, pp. 1843-1843
CHEMOEMBOLIZATION OF HEPATOCELLULAR-CARCINOMA INDUCES - CAPSULE FORMATION
Authors: THEISE ND MIZRACHI H ROSEN R GOLDENBERG A DIFLO T TOBIAS H TEPERMAN L
Citation: Nd. Theise et al., CHEMOEMBOLIZATION OF HEPATOCELLULAR-CARCINOMA INDUCES - CAPSULE FORMATION, Hepatology, 24(4), 1996, pp. 1845-1845
MRI RELIABLY DETECTS MACROREGENERATIVE NODULES AND SMALL HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC LIVERS
Authors: THEISE ND KRINSKY G MIZRACHI HH ROFSKY N GOLDENBERG A TOBIAS H DIFLO T WEINREB J TEPERMAN L
Citation: Nd. Theise et al., MRI RELIABLY DETECTS MACROREGENERATIVE NODULES AND SMALL HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC LIVERS, Hepatology, 22(4), 1995, pp. 313-313
CHANGES IN PLATELET-ASSOCIATED ANTIBODIES WITH ORTHOTOPIC LIVER-TRANSPLANTATION
Authors: GOLDENBERG A TEPERMAN L DIFLO T TOBIAS H
Citation: A. Goldenberg et al., CHANGES IN PLATELET-ASSOCIATED ANTIBODIES WITH ORTHOTOPIC LIVER-TRANSPLANTATION, Hepatology, 20(4), 1994, pp. 10000351-10000351
ELEVATIONS OF PLATELET-ASSOCIATED ANTIBODIES DURING ORTHOTOPIC LIVER-TRANSPLANT REJECTIONS
Authors: TEPERMAN L GOLDENBERG A DIFLO T TOBIAS H
Citation: L. Teperman et al., ELEVATIONS OF PLATELET-ASSOCIATED ANTIBODIES DURING ORTHOTOPIC LIVER-TRANSPLANT REJECTIONS, Hepatology, 20(4), 1994, pp. 10000406-10000406
USE OF RIBAVIRIN FOR RECURRENT HEPATITIS-C VIRUS (HCV) IN LIVER-TRANSPLANT PATIENTS AFTER FAILURE OF INTERFERON
Authors: DIETERICH DT DIFLO T POLES MA LEW EA TEPERMAN L
Citation: Dt. Dieterich et al., USE OF RIBAVIRIN FOR RECURRENT HEPATITIS-C VIRUS (HCV) IN LIVER-TRANSPLANT PATIENTS AFTER FAILURE OF INTERFERON, Gastroenterology, 106(4), 1994, pp. 10000884-10000884
RETROGRADE CAVAL FLUSH WITH PORTAL VENTING IN ORTHOTOPIC LIVER-TRANSPLANTATION
Authors: TEPERMAN LW DIFLO T
Citation: Lw. Teperman et T. Diflo, RETROGRADE CAVAL FLUSH WITH PORTAL VENTING IN ORTHOTOPIC LIVER-TRANSPLANTATION, Hepatology, 18(3), 1993, pp. 755-755
Risultati: 1-16 |